BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22812444)

  • 1. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.
    Wu X; Burden-Gulley SM; Yu GP; Tan M; Lindner D; Brady-Kalnay SM; Lu ZR
    Bioconjug Chem; 2012 Aug; 23(8):1548-56. PubMed ID: 22812444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
    Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR
    Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent.
    Wu X; Lindner D; Yu GP; Brady-Kalnay S; Lu ZR
    J Vis Exp; 2013 Sep; (79):. PubMed ID: 24056726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.
    Tan M; Ye Z; Lindner D; Brady-Kalnay SM; Lu ZR
    Pharm Res; 2014 Jun; 31(6):1469-76. PubMed ID: 23471641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging.
    Tan M; Wu X; Jeong EK; Chen Q; Lu ZR
    Biomacromolecules; 2010 Mar; 11(3):754-61. PubMed ID: 20131758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging.
    Ye Z; Wu X; Tan M; Jesberger J; Grisworld M; Lu ZR
    Contrast Media Mol Imaging; 2013; 8(3):220-8. PubMed ID: 23606425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
    Kaneshiro TL; Jeong EK; Morrell G; Parker DL; Lu ZR
    Biomacromolecules; 2008 Oct; 9(10):2742-8. PubMed ID: 18771313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide targeted high-resolution molecular imaging of prostate cancer with MRI.
    Wu X; Yu G; Lindner D; Brady-Kalnay SM; Zhang Q; Lu ZR
    Am J Nucl Med Mol Imaging; 2014; 4(6):525-36. PubMed ID: 25250202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix.
    Tan M; Wu X; Jeong EK; Chen Q; Parker DL; Lu ZR
    Mol Pharm; 2010 Aug; 7(4):936-43. PubMed ID: 20481565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
    Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
    Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.
    Ye F; Wu X; Jeong EK; Jia Z; Yang T; Parker D; Lu ZR
    Bioconjug Chem; 2008 Dec; 19(12):2300-3. PubMed ID: 19053180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.
    Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR
    Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
    Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR
    Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
    Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
    Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
    Lu ZR; Laney V; Li Y
    Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice.
    Zhang Y; Zhao J; Cai J; Ye JC; Xiao YT; Mei Y; Zeng MS; Xie CM; Jiang Y; Feng GK
    Mol Imaging Biol; 2020 Aug; 22(4):864-872. PubMed ID: 31792839
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.